A Case Report on Mucocutaneous Leishmaniasis

Abstract

Mucocutaneous Leishmaniasis (ML) can have devastating consequences, although early detection can help avoid difficulties. This research aims to explore clinical markers that can detect ML early. The protozoal infection Leishmaniasis is caused by fungal pathogens. The skin and mucosa are affected by mucocutaneous leishmaniasis (MCL). India is home to species like Leishmania donovani and Leishmania major, which cause visceral and epidermal leishmaniasis, respectively. The Main Diagnosis, Therapeutic Intervention and Outcome: Mucocutaneous Leishmaniasis was diagnosed after a physical examination and investigation by the doctor. Patient was treated antiepileptic drug and antianxiety drugs to reduce fear and anxiety. Therapeutic Intervention: Antipyretics and antibiotics such as Tab. Paracetamol, Injection Ceftriaxone 1 gm IV (BD), Tablet Pantoprazole 40 Mg iv (OD), Inj. Ondansetron 4 mg iv (TDS) were given for 7 days in this instance with Narcolepsy. Outcome: For fever, the patient was given medications prescribed by the doctor, such as paracetamol. In addition, the patient's condition improved as a result of the medical treatment. The patient's problems had subsided, and he reported feeling better. Nursing Perspectives: To control fever, the patient was given medications prescribed by the doctor, such as paracetamol. In addition, the patient's condition improved as a result of the medical treatment. The patient's problems had subsided, and he was in better shape. Conclusion: The patient was admitted to A.V.B.R. Hospital with a headache, breathing difficulties, muscle weakness, walking difficulties, reduced balance and coordination, and other symptoms. In this case of Mucocutaneous Leishmaniasis, the patient received the necessary treatment and medications. The condition of the patient had improved.